BACKGROUND: Synonymous mutations (SMs) change the mRNA nucleotide sequences without altering the corresponding amino acid sequence and are usually overlooked due to their perceived lack of influence on protein function. However, emerging reports suggest that SMs play a significant role in disease development and progression. METHODS: Whole exome sequencing, RNA-sequencing, and droplet digital PCR were performed to identify the SMs from the malignant glioma patients. MutaRNA was used to predict the effect of SMs on RNA structure in silico. SHAPE-MaP was performed to probe and assess the effect of SMs on RNA structure in-cellulo. RESULTS: Here, we report that a Cancer-Associated SM in TP53 codon valine 203 (CASM203) results in the induction of the alternative translation initiated p53 protein isoform, p47. In-cell high-throughput RNA structural mapping showed that CASM203 mimics the Protein Kinase RNA-Like ER Kinase (PERK)-mediated p53 mRNA secondary structure that induces p47 expression of during the unfolded protein response (UPR). CONCLUSIONS: Overall, the single gain-of-function SM mimics the UPR-mediated p53 stress response, by generating RNA secondary structures akin to the PERK-mediated p53 mRNA structural switch. This illustrates the link between RNA structures and cellular biology and underscores the importance of SMs in cancer biology and their potential to further refine genetic diagnostics.

Biochemistry and Molecular Biology Department University of Valencia Valencia Spain

Department of Biological Sciences and Engineering Indian Institute of Technology Palakkad Palakkad India

Department of Immunology Genetics and Pathology Uppsala University Uppsala Sweden

Department of Medical Biosciences Umea University Umea Sweden

Inserm U1131 27 Rue Juliette Dodu Paris France

RECAMO Masaryk Memorial Cancer Institute Brno Czech Republic

Research Programme on Biomedical Informatics Barcelona Spain

Zobrazit více v PubMed

Sauna ZE, Kimchi-Sarfaty C. Understanding the contribution of synonymous mutations to human disease. Nat Rev Genet. 2011;12:683–91. PubMed

Gartner JJ, Parker SC, Prickett TD, Dutton-Regester K, Stitzel ML, Lin JC, et al. Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma. Proc Natl Acad Sci USA. 2013;110:13481–6. PubMed PMC

Supek F, Minana B, Valcarcel J, Gabaldon T, Lehner B. Synonymous mutations frequently act as driver mutations in human cancers. Cell. 2014;156:1324–35. PubMed

Sharma Y, Miladi M, Dukare S, Boulay K, Caudron-Herger M, Gross M, et al. A pan-cancer analysis of synonymous mutations. Nat Commun. 2019;10:2569. PubMed PMC

Tang X, Zhang T, Cheng N, Wang H, Zheng CH, Xia J, et al. usDSM: a novel method for deleterious synonymous mutation prediction using undersampling scheme. Brief Bioinform. 2021;22:bbab123.

Rao Y, Ahmed N, Pritchard J, O’Brien EP. Incorporating mutational heterogeneity to identify genes that are enriched for synonymous mutations in cancer. BMC Bioinformatics. 2023;24:462. PubMed PMC

Niersch J, Vega-Rubin-de-Celis S, Bazarna A, Mergener S, Jendrossek V, Siveke JT, et al. A BAP1 synonymous mutation results in exon skipping, loss of function and worse patient prognosis. iScience. 2021;24:102173. PubMed PMC

Austin F, Oyarbide U, Massey G, Grimes M, Corey SJ. Synonymous mutation in TP53 results in a cryptic splice site affecting its DNA-binding site in an adolescent with two primary sarcomas. Pediatr Blood Cancer. 2017;64 https://doi.org/10.1002/pbc.26584 .

Malbert-Colas L, Ponnuswamy A, Olivares-Illana V, Tournillon AS, Naski N, Fåhraeus R. HDMX folds the nascent p53 mRNA following activation by the ATM kinase. Mol Cell. 2014;54:500–11. PubMed

Fahraeus R, Marin M, Olivares-Illana V. Whisper mutations: cryptic messages within the genetic code. Oncogene. 2016;35:3753–9. PubMed

Levine AJ. p53: 800 million years of evolution and 40 years of discovery. Nat Rev Cancer. 2020;20:471–80. PubMed

Kennedy MC, Lowe SW. Mutant p53: it’s not all one and the same. Cell Death Differ. 2022;29:983–7. PubMed PMC

Karakostis K, Vadivel Gnanasundram S, López I, Thermou A, Wang L, Nylander K, et al. A single synonymous mutation determines the phosphorylation and stability of the nascent protein. J Mol Cell Biol. 2019;11:187–99. PubMed

Bourougaa K, Naski N, Boularan C, Mlynarczyk C, Candeias MM, Marullo S, et al. Endoplasmic reticulum stress induces G2 cell-cycle arrest via mRNA translation of the p53 isoform p53/47. Mol Cell. 2010;38:78–88. PubMed

Fusee L, Salomao N, Ponnuswamy A, Wang L, Lopez I, Chen S, et al. The p53 endoplasmic reticulum stress-response pathway evolved in humans but not in mice via PERK-regulated p53 mRNA structures. Cell Death Differ. 2023;30:1072–81.

Takahashi R, Giannini C, Sarkaria JN, Schroeder M, Rogers J, Mastroeni D, et al. p53 isoform profiling in glioblastoma and injured brain. Oncogene. 2013;32:3165–74. PubMed

Pehar M, Ko MH, Li M, Scrable H, Puglielli L. P44, the ‘longevity-assurance’ isoform of P53, regulates tau phosphorylation and is activated in an age-dependent fashion. Aging Cell. 2014;13:449–56. PubMed PMC

Ungewitter E, Scrable H. Delta40p53 controls the switch from pluripotency to differentiation by regulating IGF signaling in ESCs. Genes Dev. 2010;24:2408–19. PubMed PMC

Gnanasundram SV, Malbert-Colas L, Chen S, Fusee L, Daskalogianni C, Muller P, et al. MDM2’s dual mRNA binding domains co-ordinate its oncogenic and tumour suppressor activities. Nucleic Acids Res. 2020;48:6775–87. PubMed PMC

Glimelius B, Melin B, Enblad G, Alafuzoff I, Beskow A, Ahlstrom H, et al. U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden. Acta Oncol. 2018;57:187–94. PubMed

Smola MJ, Weeks KM. In-cell RNA structure probing with SHAPE-MaP. Nat Protoc. 2018;13:1181–95. PubMed PMC

Smola MJ, Rice GM, Busan S, Siegfried NA, Weeks KM. Selective 2′-hydroxyl acylation analyzed by primer extension and mutational profiling (SHAPE-MaP) for direct, versatile and accurate RNA structure analysis. Nat Protoc. 2015;10:1643–69. PubMed PMC

Mlynarczyk C, Fahraeus R. Endoplasmic reticulum stress sensitizes cells to DNA damage-induced apoptosis through p53-dependent suppression of p21(CDKN1A). Nat Commun. 2014;5:5067. PubMed

Oakes SA. Endoplasmic reticulum stress signaling in cancer cells. Am J Pathol. 2020;190:934–46. PubMed PMC

Miladi M, Raden M, Diederichs S, Backofen R. MutaRNA: analysis and visualization of mutation-induced changes in RNA structure. Nucleic Acids Res. 2020;48:W287–91. PubMed PMC